Literature DB >> 12806623

Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas.

Martin Wagner1, Steffen Kunsch, Daniel Duerschmied, Michael Beil, Guido Adler, Friederike Mueller, Thomas M Gress.   

Abstract

BACKGROUND & AIMS: To elucidate the function of the oncofetal RNA-binding protein, K-homologous (KH) domain containing protein overexpressed in cancer (KOC), we studied the effect of a constitutive reexpression of KOC in transgenic mice.
METHODS: Transgenic mouse lines expressing KOC under the control of the mouse metallothionein promoter were generated and were shown to express the 69-kilodalton protein. Two mouse lines with moderate to strong gene expression of the transgene were further analyzed.
RESULTS: The pancreas of KOC-transgenic mice showed progressive morphologic alterations, including an increased proliferation of acinar cells, acinar-ductal metaplasia, net loss of acinar tissue, and the appearance of numerous interstitial cells. Acinar-ductal metaplasia led to the development of duct-like structures exhibiting the characteristics of normal intralobular ducts. Interstitial cells expressed markers of endocrine or ductal differentiation. Nerve growth factor alpha (NGF-alpha) and the GTPase kir/Gem were identified as potential targets of KOC by expression profiling analyses.
CONCLUSIONS: Reexpression of KOC in the transgenic model is apparently incompatible with the maintenance of a fully differentiated, adult acinar phenotype and may lead to a more fetal ductal phenotype via acinar-ductal metaplasia. This and the appearance of interstitial cells with a ductal and endocrine differentiation capacity suggest that transgenic reexpression of the oncofetal gene KOC may recapitulate a developmental program active during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806623     DOI: 10.1016/s0016-5085(03)00402-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

3.  IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.

Authors:  Qiong Huang; Ji-ye Yin; Xing-ping Dai; Qi Pei; Min Dong; Zhi-guang Zhou; Xi Huang; Min Yu; Hong-hao Zhou; Zhao-qian Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

4.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.

Authors:  David F Schaeffer; Daniel R Owen; Howard J Lim; Andrew K Buczkowski; Stephen W Chung; Charles H Scudamore; David G Huntsman; Sylvia S W Ng; David A Owen
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

5.  RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.

Authors:  Jayanth Kumar Palanichamy; Tiffany M Tran; Jonathan M Howard; Jorge R Contreras; Thilini R Fernando; Timothy Sterne-Weiler; Sol Katzman; Masoud Toloue; Weihong Yan; Giuseppe Basso; Martina Pigazzi; Jeremy R Sanford; Dinesh S Rao
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

6.  SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.

Authors:  Sita Kugel; Carlos Sebastián; Julien Fitamant; Kenneth N Ross; Supriya K Saha; Esha Jain; Adrianne Gladden; Kshitij S Arora; Yasutaka Kato; Miguel N Rivera; Sridhar Ramaswamy; Ruslan I Sadreyev; Alon Goren; Vikram Deshpande; Nabeel Bardeesy; Raul Mostoslavsky
Journal:  Cell       Date:  2016-05-12       Impact factor: 41.582

7.  The rs11705701 G>A polymorphism of IGF2BP2 is associated with IGF2BP2 mRNA and protein levels in the visceral adipose tissue - a link to type 2 diabetes susceptibility.

Authors:  Dimitry A Chistiakov; Alexey G Nikitin; Svetlana A Smetanina; Larisa N Bel'chikova; Lyudmila A Suplotova; Marina V Shestakova; Valery V Nosikov
Journal:  Rev Diabet Stud       Date:  2012-11-15

8.  Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.

Authors:  Thomas V O Hansen; Niels A Hammer; Jacob Nielsen; Mette Madsen; Charlotte Dalbaeck; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.

Authors:  R Mizutani; N Imamachi; Y Suzuki; H Yoshida; N Tochigi; T Oonishi; Y Suzuki; N Akimitsu
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

10.  IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.

Authors:  Hanane Ennajdaoui; Jonathan M Howard; Timothy Sterne-Weiler; Fereshteh Jahanbani; Doyle J Coyne; Philip J Uren; Marija Dargyte; Sol Katzman; Jolene M Draper; Andrew Wallace; Oscar Cazarez; Suzanne C Burns; Mei Qiao; Lindsay Hinck; Andrew D Smith; Masoud M Toloue; Benjamin J Blencowe; Luiz O F Penalva; Jeremy R Sanford
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.